Google Share on Facebook chronic toxicity treatment Translations Spanish / Español Select a language: n.tratamiento prolongado de cualquiera toxicidad. English-Spanish Medical Dictionary © Farlex 2012 Want to thank TFD for its existence?Tell a friend about us, add a link to this page, or ...
Monitor patients for signs and symptoms of infection before and after CARVYKTI®infusion and treat patients appropriately. Administer prophylactic, pre-emptive and/or therapeutic antimicrobials according to the sta...
Neutropenia was the most common grade 3+ trAE for both chemo (n=5) and chemoIO (n=4). Overall, there were no significant differences between chemo or chemoIO groups for ORR (p=0.81), all-grade trAEs (p=0.88), grade 3+ trAEs (p=0.84), PFS (p=0.86), or median OS (p=0.66)....
Even despite intensive induction therapies, relapse rates are high and prognosis of PTCL remains poor as compared to their malignant B-cell counterparts. Historically, 5-year PFS for PTCL (excluding non ALK-positive ALCL) is approximately 20% and up to 30% of patients may be primary refractory ...
Lung Cancer:Targets and Therapy 2017:8 Powered by TCPDF (www.tcpdf.org) submit your manuscript | www.dovepress.com Dovepress 187 Mudad et al Supplementary materials Table S1 Adverse event ICD-9-CM codes Adverse event Neutropenia Leukocytopenia, unspecified Chemotherapy-induced anemia Iron ...
We excluded events that were reported as related to disease progression, but included all events with unspecified attribution and included events regardless of attribution to treatment provided that they were not related to disease progression. Analyses were performed by using Stata version 12.0 software...
The most common adverse reactions (incidence ≥ 20%) in patients with LBCL in ZUMA-1 included CRS, fever, hypotension, encephalopathy, tachycardia, fatigue, headache, decreased appetite, chills, diarrhea, febrile ...
Eight patients were accrued: two peripheral T cell lymphoma, unspecified; five angioimmunoblastic T cell lymphoma; and one ALK-negative anaplastic large-cell lymphoma. A dose escalation of lenalidomide (days 1–21, q28) was planned using a 3+3 design. As two patients treated with 10mg/day ...
The most common non-laboratory adverse reactions (incidence ≥ 20%) in patients with LBCL in ZUMA-7 included fever, CRS, fatigue, hypotension, encephalopathy, tachycardia, diarrhea, headache, musculoskeletal pain, nausea, febrile neutropenia, chills, cough, infection with unspecified pathogen, dizzines...
poisoning and procedural complications Fracture 22 1 1 Neoplasms benign, malignant and unspecified Leukaemia secondary to oncology chemotherapy 1 1 11 Renal and urinary disorders Cystitis non infected 00 11 Abbreviations: ALT ¼ alanine aminotransferase; AST ¼ aspartate aminotransferase; G/D ¼ Gemc...